Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on May 22, 2025
Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 22, 2025
WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models …
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 22, 2025
MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the 2025 …
Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
GlobeNewswire
·
May 22, 2025
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that it has commenced an underwritten public offering of shares of its …
Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
GlobeNewswire
·
May 22, 2025
Immix Biopharma today reported ASCO abstract results from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201 demonstrating strong efficacy and favorable safety. – NXC-201 demonstrated a complete response (CR) rate of 71% (5/7 patients) – …
Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire
·
May 22, 2025
ISELIN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced an …
Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China
GlobeNewswire
·
May 22, 2025
Achieved statistically significant ≥1-stage fibrosis regression at Week 52 vs. placebo (52.85% vs. 29.84%, P=0.0002). Demonstrated favorable safety and tolerability profile: 4.88% serious adverse events vs. 6.45% for placebo; zero discontinuations due to …
Premature Ejaculation Treatment Market Set to Witness Significant Growth by 2025-2032 | Regent Pacific Group Limited
EIN Presswire
·
May 22, 2025
BURLINGAME, CA, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The qualitative latest Research report (2025-2032) on the Premature Ejaculation Treatment Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, …
Global Drug Formulation Market to Hit USD 2.8 Trillion by 2035 Amidst Rising Demand for Advanced Oral Formulations | FMI
EIN Presswire
·
May 22, 2025
Comprehensive insights into the global Drug Formulation Market, highlighting growth trends, innovations, and future opportunities. NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The global drug formulation market is set for remarkable …
PESG Research Report: A Review of Silexion Therapeutics' Innovative KRAS-Driven Cancer Treatment
GlobeNewswire
·
May 22, 2025
New York, May 22, 2025 (GLOBE NEWSWIRE) -- PESG Research today announced the release of a report examining Silexion Therapeutics, an innovative biotechnology company developing unique RNA interference (RNAi) therapies targeting KRAS-driven cancers. The …
Anti-Biofilm Wound Dressing Market Poised for Significant Growth to Reach USD 2,403.1 Million by 2035 a CAGR 9.8% | FMI
EIN Presswire
·
May 22, 2025
Rising demand for infection prevention drives growth in the global anti-biofilm wound dressing market, advancing wound care solutions worldwide NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The global anti-biofilm wound dressing market …
Pupillometer Market Set for Robust Growth with Cutting-Edge Technological Advances and Rising Clinical Demand | FMI
EIN Presswire
·
May 22, 2025
Rising Demand for Neurological Diagnostics Propels Growth in the Global Pupillometer Market NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- A growing tide of technological innovation, increasing prevalence of neurological and ophthalmic …
Global Wheelchair Market Set to Surpass USD 9,804.9 Million by 2034 Amidst Soaring Demand for Mobility Solutions | FMI
EIN Presswire
·
May 22, 2025
Global Wheelchair Market Set to Expand Significantly Through 2034 – Insights on Size, Share, Trends …
SOAX Acquires ProxyWow to Strengthen Infrastructure and Accelerate Access to Reliable Web Data at Scale
EIN Presswire
·
May 22, 2025
Strategic acquisition boosts SOAX’s infrastructure …
Citrin Foundation and University Children’s Hospital Zürich Launch First Center for Translational Research in UCD
EIN Presswire
·
May 22, 2025
Pioneering translational model combines cutting-edge science, clinical leadership, global collaboration, and a patient-first mission to unlock new therapies LONDON, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- The Citrin Foundation and the …
Recode Ventures' Vishal Gulati Elected Fellow Of Academy Of Medical Sciences For Contributions To Translational Medicine
EIN Presswire
·
May 22, 2025
Healthcare Venture Capitalist Vishal Gulati Inducted Into The Academy Of Medical Sciences In Recognition Of His Role In Translational Medicine. LONDON, UK, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- Recode Ventures is honoured to announce that …
Houston Emerges as Global Center for Brain Health Innovation
GlobeNewswire
·
May 22, 2025
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Protecting and enriching human brain health and performance may be one of the most important economic strategies that businesses and governments pursue as they seek to strengthen workforces, mitigate the surging …
Endurance Bio Inc. Announces Selection of T-168 for Neuro-SysMed’s SLEIPNIR Platform Trial in Parkinson’s Disease
GlobeNewswire
·
May 22, 2025
SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Endurance Bio Inc., a clinical-stage biotechnology company developing therapies for neurodegenerative and metabolic diseases, today announced that its compound, T-168, has been selected for testing on …
Creative Biolabs Introduces Game-Changing CRISPR Solutions for Accelerated Gene Therapy Development
EIN Presswire
·
May 22, 2025
By leveraging the potential of CRISPR gene editing technology, Creative Biolabs provides custom gene therapy development solutions to accelerate your research. SHIRLEY, NY, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The gene therapy landscape has …
Mobile Clinic Market is likely to reach USD 6.7 Billion by 2034 expanding at a CAGR of 7% | FMI
EIN Presswire
·
May 22, 2025
Explore growth trends, market share, and future projections for the global mobile clinic market from 2024 to 2034 NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The global mobile clinic market is undergoing a remarkable transformation. …
Investornomy, Led by Dr. Linda Pajoel, Broadens Mission to Teach Both Men and Women Self-Directed Stock Investing
EIN Presswire
·
May 22, 2025
Expanded offerings reflect Investornomy’s belief that investing should be accessible and empowering for everyone ONTARIO, CANADA, May 22, 2025 /EINPresswire.com/ -- Investornomy, the leading stock investing education platform founded and led by Dr. …